These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 17537383

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Management of myasthenia gravis.
    Saperstein DS, Barohn RJ.
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Myasthenia gravis.
    Silvestri NJ, Wolfe GI.
    Semin Neurol; 2012 Jul; 32(3):215-26. PubMed ID: 23117946
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intravenous immune globulin in myasthenia gravis.
    Gajdos P.
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The treatment of patients with myasthenia gravis.
    Sanders DB, Scoppetta C.
    Neurol Clin; 1994 May; 12(2):343-68. PubMed ID: 8041346
    [Abstract] [Full Text] [Related]

  • 12. Maintenance immunosuppression in myasthenia gravis.
    Gotterer L, Li Y.
    J Neurol Sci; 2016 Oct 15; 369():294-302. PubMed ID: 27653912
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current and future therapies for myasthenia gravis.
    Yi Q, Lefvert AK.
    Drugs Aging; 1997 Aug 15; 11(2):132-9. PubMed ID: 9259176
    [Abstract] [Full Text] [Related]

  • 16. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
    Oosterhuis HJ.
    Ned Tijdschr Geneeskd; 1983 Sep 24; 127(39):1765-71. PubMed ID: 6314161
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Immunosuppressive / immunomodulating therapies in myasthenia gravis-at present and in the near future].
    Kawaguchi N.
    Brain Nerve; 2011 Jul 24; 63(7):737-43. PubMed ID: 21747144
    [Abstract] [Full Text] [Related]

  • 19. Treatment of autoimmune myasthenia gravis.
    Richman DP, Agius MA.
    Neurology; 2003 Dec 23; 61(12):1652-61. PubMed ID: 14694025
    [Abstract] [Full Text] [Related]

  • 20. Development of novel therapies for MG: Studies in animal models.
    Souroujon MC, Brenner T, Fuchs S.
    Autoimmunity; 2010 Aug 23; 43(5-6):446-60. PubMed ID: 20298126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.